Lung Cancer Therapeutics Market
According to Intent Market Research, the Lung Cancer Therapeutics Market is expected to grow from USD 31.5 Billion in 2024-e at a CAGR of 12.2% to touch USD 62.8 Billion by 2030. The Lung Cancer Therapeutics Market is dominated by key players such as, AstraZeneca, Pfizer Inc., Merck & Co., Inc., Roche Holding AG, Bristol-Myers Squibb Company, and Novartis AG.